Disc Medicine Stock Price Prediction

IRON Stock   55.60  0.28  0.50%   
As of today, the RSI of Disc Medicine's share price is approaching 47. This usually indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Disc Medicine, making its price go up or down.

Oversold Vs Overbought

47

 
Oversold
 
Overbought
The successful prediction of Disc Medicine's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Disc Medicine, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Disc Medicine's stock price prediction:
EPS Estimate Next Quarter
(1.28)
EPS Estimate Current Year
(4.08)
EPS Estimate Next Year
(5.19)
Wall Street Target Price
94.8182
EPS Estimate Current Quarter
(1.05)
Using Disc Medicine hype-based prediction, you can estimate the value of Disc Medicine from the perspective of Disc Medicine response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Disc Medicine using Disc Medicine's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Disc using crowd psychology based on the activity and movement of Disc Medicine's stock price.

Disc Medicine Implied Volatility

    
  0.72  
Disc Medicine's implied volatility exposes the market's sentiment of Disc Medicine stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Disc Medicine's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Disc Medicine stock will not fluctuate a lot when Disc Medicine's options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Disc Medicine to buy its stock at a price that has no basis in reality. In that case, they are not buying Disc because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Disc Medicine after-hype prediction price

    
  USD 55.6  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.

Prediction based on Rule 16 of the current Disc contract

Based on the Rule 16, the options market is currently suggesting that Disc Medicine will have an average daily up or down price movement of about 0.045% per day over the life of the 2025-03-21 option contract. With Disc Medicine trading at USD 55.6, that is roughly USD 0.025 . If you think that the market is fully incorporating Disc Medicine's daily price movement you should consider acquiring Disc Medicine options at the current volatility level of 0.72%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Check out Disc Medicine Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Disc Stock, please use our How to Invest in Disc Medicine guide.
Intrinsic
Valuation
LowRealHigh
51.6455.8760.10
Details
Naive
Forecast
LowNextHigh
53.8058.0362.27
Details
11 Analysts
Consensus
LowTargetHigh
85.1393.55103.84
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-1.11-1.02-0.85
Details

Disc Medicine After-Hype Price Prediction Density Analysis

As far as predicting the price of Disc Medicine at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Disc Medicine or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Disc Medicine, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Disc Medicine Estimiated After-Hype Price Volatility

In the context of predicting Disc Medicine's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Disc Medicine's historical news coverage. Disc Medicine's after-hype downside and upside margins for the prediction period are 51.37 and 59.83, respectively. We have considered Disc Medicine's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
55.60
55.60
After-hype Price
59.83
Upside
Disc Medicine is very steady at this time. Analysis and calculation of next after-hype price of Disc Medicine is based on 3 months time horizon.

Disc Medicine Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Disc Medicine is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Disc Medicine backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Disc Medicine, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.04 
2.96
  0.06 
  0.01 
10 Events / Month
16 Events / Month
In about 10 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
55.60
55.60
0.00 
209.93  
Notes

Disc Medicine Hype Timeline

Disc Medicine is currently traded for 55.60. The entity has historical hype elasticity of -0.06, and average elasticity to hype of competition of -0.01. Disc is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is estimated to be very small, whereas the daily expected return is currently at -0.04%. %. The volatility of related hype on Disc Medicine is about 1631.5%, with the expected price after the next announcement by competition of 55.59. About 84.0% of the company shares are owned by institutional investors. The book value of Disc Medicine was currently reported as 15.73. The company recorded a loss per share of 3.95. Disc Medicine had not issued any dividends in recent years. The entity had 1:30 split on the 30th of December 2022. Given the investment horizon of 90 days the next estimated press release will be in about 10 days.
Check out Disc Medicine Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Disc Stock, please use our How to Invest in Disc Medicine guide.

Disc Medicine Related Hype Analysis

Having access to credible news sources related to Disc Medicine's direct competition is more important than ever and may enhance your ability to predict Disc Medicine's future price movements. Getting to know how Disc Medicine's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Disc Medicine may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
ANEBAnebulo Pharmaceuticals(0.02)6 per month 0.00 (0.02) 7.64 (10.43) 40.03 
ADAGAdagene 0.04 7 per month 0.00 (0.11) 5.26 (8.33) 41.45 
ACRVAcrivon Therapeutics, Common 0.47 3 per month 0.00 (0.1) 8.45 (9.66) 26.67 
ANABAnaptysBio 0.35 12 per month 0.00 (0.11) 8.22 (8.03) 44.55 
MLYSMineralys Therapeutics, Common 0.71 7 per month 0.00 (0.09) 7.79 (6.95) 26.52 
OLMAOlema Pharmaceuticals 0.12 10 per month 0.00 (0.15) 7.39 (12.02) 31.66 
LRMRLarimar Therapeutics(0.20)9 per month 0.00 (0.17) 8.30 (10.56) 33.48 
FENCFennec Pharmaceuticals(0.06)8 per month 3.53  0.12  7.87 (6.75) 23.48 
OBIOOrchestra BioMed Holdings(0.25)6 per month 4.90 (0.0004) 7.62 (7.67) 40.72 
BMEABiomea Fusion(0.30)8 per month 0.00 (0.27) 6.48 (11.36) 28.29 
GPCRStructure Therapeutics American(2.40)8 per month 0.00 (0.08) 7.11 (7.98) 22.37 
DICEDice Molecules Holdings 0.02 7 per month 1.14  0.11  5.66 (2.91) 37.64 
MORFMorphic Holding 0.08 10 per month 2.23  0.12  8.98 (4.94) 75.26 
TERNTerns Pharmaceuticals 0.03 10 per month 0.00 (0.19) 5.17 (6.75) 26.61 
DAWNDay One Biopharmaceuticals(0.21)8 per month 0.00 (0.09) 4.00 (3.46) 11.05 
ABOSAcumen Pharmaceuticals(0.16)9 per month 0.00 (0.19) 7.36 (7.10) 24.44 
AMLXAmylyx Pharmaceuticals(0.32)11 per month 0.00 (0.10) 7.40 (8.97) 20.49 
MLTXMoonLake Immunotherapeutics 0.46 8 per month 3.48 (0.01) 4.74 (5.69) 15.60 
CRNXCrinetics Pharmaceuticals(2.73)7 per month 0.00 (0.18) 3.10 (7.53) 21.52 
CNTACentessa Pharmaceuticals PLC 0.71 10 per month 3.58  0.04  6.35 (6.19) 15.71 
TRDAEntrada Therapeutics(0.15)8 per month 0.00 (0.12) 4.16 (7.32) 15.93 

Disc Medicine Additional Predictive Modules

Most predictive techniques to examine Disc price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Disc using various technical indicators. When you analyze Disc charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Disc Medicine Predictive Indicators

The successful prediction of Disc Medicine stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Disc Medicine, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Disc Medicine based on analysis of Disc Medicine hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Disc Medicine's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Disc Medicine's related companies.

Story Coverage note for Disc Medicine

The number of cover stories for Disc Medicine depends on current market conditions and Disc Medicine's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Disc Medicine is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Disc Medicine's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Disc Medicine Short Properties

Disc Medicine's future price predictability will typically decrease when Disc Medicine's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Disc Medicine often depends not only on the future outlook of the potential Disc Medicine's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Disc Medicine's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding22.3 M
Cash And Short Term Investments360.4 M
When determining whether Disc Medicine offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Disc Medicine's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Disc Medicine Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Disc Medicine Stock:
Check out Disc Medicine Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Disc Stock, please use our How to Invest in Disc Medicine guide.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Disc Medicine. If investors know Disc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Disc Medicine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.95)
Return On Assets
(0.18)
Return On Equity
(0.25)
The market value of Disc Medicine is measured differently than its book value, which is the value of Disc that is recorded on the company's balance sheet. Investors also form their own opinion of Disc Medicine's value that differs from its market value or its book value, called intrinsic value, which is Disc Medicine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Disc Medicine's market value can be influenced by many factors that don't directly affect Disc Medicine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Disc Medicine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Disc Medicine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Disc Medicine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.